Trump’s Drug Pricing Order Raises Questions of Effectiveness
On May 12, 2025, President Trump issued an Executive Order aimed at lowering U.S. drug prices by implementing most-favored-nation pricing.
The order criticizes the disparity in drug prices between the U.S. and other countries, seeking to end 'global freeloading' and 'inflated prices' in the U.S.
Experts doubt the immediate effectiveness of the order, describing it as more about applying leverage than actual policymaking
Trump claims prices will fall by 30% to 80%, but the timeline and specifics remain unclear.